- CSR Summary Not Available
- NCT04614948
- Primary Citation
Trial Information
Generic NameAd26.COV2.SProduct NameJanssen COVID-19 VaccineTherapeutic AreaInfectious Disease & VaccinesEnrollment31831% Female47.3%% White76.3%
Product ClassN/ASponsor Protocol NumberVAC31518COV3009Data PartnerJohnson & JohnsonCondition StudiedCoronavirus DiseaseMean/Median Age (Years)53.0
Supporting Documentation
- Collected Datasets Available
- Data Definition Specification Available
- Protocol with Amendments Available
- Statistical Analysis Plan Available
- Clinical Study Report Available